{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-089787","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2022-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.549227+00:00","generated_at":"2026-06-26T13:38:18.193287+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cue Biopharma signs 4-year license for Boston office/lab space; monthly rent $200,700","bullets":["Lease covers ~13,000 sq ft at 40 Guest Street, Boston; term April 15, 2022 to April 14, 2026.","Monthly base rent $200,700 first year, escalating 4% annually: Year2 $208,728, Year3 $217,077, Year4 $225,760.","Initial payment due at signing: $652,220.40 plus parking fees (20 spaces).","Company plans to relocate corporate headquarters to the Premises in April 2022.","Licensor (MIL 40G) provides services including gases, chemicals, equipment, IT, security."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-089787","json":"https://secwatch.observer/filing/0001193125-22-089787.json","markdown":"https://secwatch.observer/filing/0001193125-22-089787.md","text":"https://secwatch.observer/filing/0001193125-22-089787.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000119312522089787/0001193125-22-089787-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000119312522089787/d339157d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T13:38:18.193287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}